Intractable mycobacterial infections associated with genetic defects in the receptor for interferon gamma: What does this tell us about immunity to mycobacterial?

Thorax

Volumn 52, Issue SUPPL. 3, 1997, Pages

  Rook, Graham A W ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; GAMMA INTERFERON; INTERFERON RECEPTOR; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; BACTERIAL IMMUNITY; BCG VACCINATION; CASE REPORT; CHILD; CHROMOSOME 6Q; CHRONIC GRANULOMATOUS DISEASE; COMBINED IMMUNODEFICIENCY; CONTROLLED STUDY; DISEASE ASSOCIATION; GENE MAPPING; GENE MUTATION; GENETIC SUSCEPTIBILITY; HUMAN; MYCOBACTERIOSIS; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; PHAGOCYTE; PRIORITY JOURNAL; RECEPTOR GENE; RESPIRATORY BURST;

EID: 0030856683     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.52.2008.s41     Document Type: Article

References (32)

1. Jouanguy E, Altare F, Lamhamedi S, Revy P, Emile J-F. Newport M, et al. Interferon-γ receptor deficiency in an infant with fatal Bacille Calmette-Guérin infection. N Engl J Med 1996;335:1956-61.
2. Newport M, Huxley CM, Huston S, Hawrylowicz CM, Oostra BA. Williamson R, et al. A mutation in the interferon-γ receptor gene and susceptibility to mycobacterial infection. N Engl J Med 1996;335:1941-9.
3. Casanova J-L, Blanche S, Emile J-F, Jouanguy E, Lamhamedi S, Altare F, et al. Idiopathic disseminated bacillus Calmette-Guerin (BCG) infection: a French national retrospective study. Pediatrics 1996;98:774-8.
4. Levin M, Newport M, D'Souza S, Kalabalikis P, Brown IN. Lenicker HM, et al. Familial disseminated atypical mycobacterial infection in childhood: a mycobacterial susceptibility gene? Lancet 1995;345:79-83.
5. Dalton DK, Pitts-Meek S, Keshav S, Figari IS, Bradley A. Stewart TA. Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science. 1993;259:1739-12.
6. Flynn JL, Chan J, Triebold KJ, Dalton DK, Stewart TA, Bloom BR. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J Exp Med 1993;178:2249-54.
7. Flynn JL, Goldstein MM, Chan J, Triebold KJ, Pfeffer K, Lowenstein CJ, et al. Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity 1995;2:561-72.
8. Kamijo R, Le J, Shapiro D, Havell EA, Huang S, Aguet M, et al. Mice that lack the interferon-γ receptor have profoundly altered responses to infection with bacillus Calmette Guérin and subsequent challenge with lipopolysaccharide. J Exp Med 1993;178:1435-40.
9. Kamijo R, Harada H, Matsuyama T, Bosland M, Gerecitano J, Shapiro D, et al. Requirement for transcription factor IRF-1 in NO synthase induction in macrophages. Science. 1994;263:1612-5.
10. Sacco RE, Jensen RJ, Thoen CO, Sandor M, Weinstock J, Lynch RG, et al. Cytokine secretion and adhesion molecule expression by granuloma T lymphocytes in Mycobacterium avium infection. Am J Pathol 1996;148:1935-48.
11. Holland SM, Eisenstein EM, Kuhns DB, Turner ML, Fleisher TA, Strober W, et al. Treatment of refractory disseminated nontuberculous mycobacterial infection with interferon gamma. A preliminary report. N Engl J Med 1994;330:1348-55.
12. Tishon A, Lewicki H, Rail G, von Herrath M, Oldstone MB. An essential role for type 1 interferon gamma in terminating persistent viral infection. Virology 1995;212:244-50.
13. D'Souza S, Levin M, Faith A, Yssel H, Bennett B, Lake RA, et al. Defective antigen processing associated with familial disseminated mycobacteriosis. Clin Exp Immunol 1996;103:35-9.
14. Kamijo R, Shapiro D, Le J, Huang S, Aguet M, Vilcek J. Generation of nitric oxide and induction of major histocompatibility complex class II antigen in macrophages from mice lacking the interferon gamma receptor. Proc Natl Acad Sci USA 1993;90:6626-30.
15. Casanova J-L, Jouanguy E, Lamhamedi S, Blanche S, Fischer A. Immunological conditions of children with BCG disseminated infection, Lancet 1995;346:581.
16. Kindler V, Sappino AP, Grau GE, Piguet PF, Vassalli P. The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection. Cell 1989;56:731-40.
17. Chan J, Xing Y, Magliozzo RS, Bloom BR. Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages. J Exp Med 1992;175:1111-22.
18. Szabo C. The pathophysiological role of peroxynitrite in shock, inflammation, and ischemia-reperfusion injury. Shock 1996;6:79-88.
19. Rook CAW, Steele J, Fraher L, Barker S, Karmah K, O'Riordan J, et al. Vitamin D3, gamma Interferon, and control of proliferation of Mycobacterium tuberculosis by human monocytes. Immunology 1986;57:159-63.
20. Rook GAW, Steele J, Amsworth M, Champion BR. Activation of macrophages to inhibit proliferation of Mycobacterium tuberculosis: comparison of the effects of recombinant gamma- interferon on human monocytes and murine peritoneal macrophages, Immunology 1986;59:333-8.
21. Weinberg JB, Misukonis MA, Shami PJ, Mason SN, Sauls DL, Dittman ER, et al. Human mononuclear phagocyte inducible nitric oxide synthase (iNOS); analysis of iNOS mRNA, iNOS protein, biopterin, and nitric oxide production by blood monocytes and peritoneal macro-phages. Blood 1995;86:1184-95.
22. Reiling N, Ulmer AJ, Duchrow M, Ernst M, Flad HD, Hauschildt S. Nitric oxide synthase: mRNA expression of different isoforms in human monocytes/macrophages. Eur J Immunol 1994;24:191-4.
23. Nicholson S, Bonecini-Almeida MG, Lapa e Silva JR. Nathan C, Xie Q, Mumford R, et al. Inducible nitric oxide synthase in pulmonary alveolar macrophages from patients with tuberculosis. J Exp Med 1996;183:2293-302.
24. Dugas B, Mossalayi MD, Damais C, Kolb J-P. Nitric oxide production by human monocytes: evidence for a role of CD23. Immunol Today 1995;16:574-80.
25. Paul-Eugene N, Mossalayi D, Sarfati M, Yamaoka K, Aubry JP, Bonnefoy JY. et al. Evidenece for a role of Fc epsilon RII/CD23 in the IL4-induced nitric oxide production by normal human mononuclear phagocytes. Cell Immun, 1995;163:314-8.
26. Vouldoukis I, Riveyros-Moreno V, Dugas B, Ouaaz F, Becherel P, Debre P, et al. The killing of Leishmania major by humun macrophages is mediated by nitric oxide induced after ligation of the Fc epsilon RII CD23 surface antigen. Proc Natl Acad Sci USA 1995;92:7804-8.
27. Yong AJ, Grange JM, Tee RD, Beck JS, Bothamley GH, Kemeny DM, et al. Total and anti-mycobacterial IgH IgE levels in serum from patients with tuberculosis and leprosy. Tubercle 1989;70:273-9.
28. Schauf V, Rom WN, Smith KA, Sampaio EP, Meyn PA, Tramontana JM, et al. Cytokine gene activation and modified rcsponsiveness to interleukin-2 in the blood of tuberculosis patients. J Infect Dis 1993;168:1056-9.
29. Rook GAW, Hernandez-Pando R. The pathogenesis of tuberculosis. Annu Rev Microbiol 1996;50:259-84.
30. Taylor AP, Murray HW. Intracellular antimicrobial actiyity in the absence of interferon- γ: effect of interleukin-12 in experimental visceral leishmaniasis in interferon-γ gene-disrupted mice. J Exp Med 1997;185:1231-9.
31. Evans TJ, Buttery LKD, Carpenter A, Springali DR, Polak JM. Cytokine-treated human neutrophils contain inducible nitric oxide synthase that produces nitration of igested bacteria, Proc Natl Acad Sci USA 1996;93:9553-8.
32. 2 induces monocyte apoptosis and reduces viability of Mycobacterium avium-M intracellular within cultured human monocytes. Infect Immun 1996;64:452-9.